Precision Neuroscience raises $102M Series C

Precision Neuroscience/Layer 7 Cortical Interface

Precision Neuroscience announced a $102M Series C funding round led by General Equity Holdings with B Capital, Duquesne Family Office and Steadview Capital participating, bringing total funding to $155M. The capital funds clinical research and next-generation device development. By the funding date, the thin-film Layer 7 implant had been tested in 27 patients at Mount Sinai, Penn and West Virginia University.

• Series C led by General Equity Holdings; investors also include earlier backers B Capital, Duquesne Family Office and Steadview Capital.
• Clinical progress: Layer 7 array tested in 27 patients across three major institutions for intraoperative brain mapping and neurosurgical monitoring.
• Funding accelerates clinical research toward commercialization and enables development of future wireless BCI device iterations.